CMS mandates 180-day Part D claims
CMS has mandated that Part D drug plans allow 180 days for filingclaims incurred between Jan. 1 and June 30. Problems withcoordination of benefits have required the reversal of claims andrebilling to the appropriate payer. Since a lack of information ledpharmacies to sometimes bill the wrong payer, they should not beheld to the usual 30- to 90-day timely billing standard, CMSconcluded.
CMS mandates 180-day Part D claims
CMS has mandated that Part D drug plans allow 180 days for filing claims incurred between Jan. 1 and June 30. Problems with coordination of benefits have required the reversal of claims and rebilling to the appropriate payer. Since a lack of information led pharmacies to sometimes bill the wrong payer, they should not be held to the usual 30- to 90-day timely billing standard, CMS concluded. The agency mandated the 180-day window after some Part D plans failed to create appropriate claims filing rules as CMS had requested.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
